Dialco’s selection of CROMSOURCE as their partner for their DIMI IDE trial reinforces CROMSOURCE’s position as a global leader in conducting medical device trials.
“The CROMSOURCE team is excited to partner with such a recognized global leader as Dialco and their parent, Spectral Medical. While our experience in managing medical device trials is important to Dialco, our flexibility and adaptability, particularly during a global pandemic, make us the ideal partner. We look forward to a long-term and productive partnership with the Dialco team,” said Dr. McCall.
Read the full press release here